tracken
Mirum Pharmaceuticals Inc Aktie News
Neutral
Business Wire
●
12 Tage alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Neutral
Business Wire
●
15 Tage alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharma Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting®.
Neutral
Seeking Alpha
●
18 Tage alt
Mirum Pharmaceuticals, Inc. ( MIRM ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Andrew McKibben - Senior Vice President, Strategic Finance & Investor Relations Christopher Peetz - CEO & Director Peter Radovich - COO & President Joanne M. Quan - Chief Medical Officer Eric Bjerkholt - Chief Financial Officer Conference Call Participants Abdulqudus Tahlil - JPMorgan Ch...
Neutral
Business Wire
●
18 Tage alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update.
Neutral
Business Wire
●
19 Tage alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences.
Neutral
Business Wire
●
25 Tage alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025.
Neutral
Business Wire
●
etwa ein Monat alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Neutral
Business Wire
●
2 Monate alt
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
